Opinion

Video

ASCO 2024 Highlights: Long-Term Data and the Future of Combination Therapies in Melanoma

Dr Lipson provides insights surrounding combination therapies in melanoma management.

Video content above is prompted by the following:

  • What is the value of long-term follow-up data in melanoma? How does this impact use of treatment regimens?
  • How do you foresee the role of combination therapies evolving in the treatment of melanoma over the next few years?
Related Videos
1 KOL is featured in this series.
1 expert is featured in this series.
5 experts are featured in this series
5 experts are featured in this series.
1 KOL is featured in this series.
Related Content
Highlights From ASCO 2024
December 21st 2024

ICYMI: Highlights From ASCO 2024

Pearl Steinzor
Top coverage from the 2024 American Society of Clinical Oncology (ASCO) annual meeting included research topics in non-small cell lung cancer (NSCLC), multiple myeloma, metastatic colorectal cancer (mCRC), and more.
Highlights from SLEEP 2024
December 18th 2024

ICYMI: Highlights From SLEEP 2024

Kyle Munz
Check out our top 5 most-viewed pieces of coverage from the 2024 SLEEP meeting.
ICYMI: Highlights From ACTRIMS 2024
December 12th 2024

ICYMI: Highlights From ACTRIMS 2024

Kyle Munz
Read about the diverse array of research presented at this year's meeting, including novel technological advancements and insights into disease progression in multiple sclerosis (MS).

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo